Abstract
Anaplasma marginale is a tick-transmitted Gram-negative intraerythrocytic bacterium and the etiological agent of bovine Anaplasmosis. Even though considerable research efforts have been undertaken, Anaplasmosis vaccine development remains a challenging field. Outer-membrane-specific antigens responsible for the ability of more complex immunogens could have a significant role in the protective response. Thus, the identification of outer-membrane antigens represents a major goal in the development of bacterial vaccines. Considering that 40 % of the annotated proteins in A. marginale remain as hypothetical, we selected three candidate antigens, AM1108, AM127, and AM216 based on experimental evidence, in silico structure prediction of β-barrel outer membrane, and orthology clustering. Sequence alignment and analysis demonstrated a high degree of conservation for the three proteins between the isolates from Argentina compared to the American strains. We confirmed the transcription of the three genes in the intraerythrocytic stage. AM1108 and AM216 recombinant proteins elicited specific T-cell response proliferation and a significant rise in TNF-α and IFN-γ transcript levels, respectively. Only AM1108 was able to be recognized by specific antibodies from infected bovines. This study allowed the identification of new candidate components of the outer-membrane fraction of A. marginale. Further studies will be required to analyze their potential as effective antigens for being included in rational vaccine strategies.
Similar content being viewed by others
Introduction
Intracellular rickettsial pathogens of the Anaplasmataceae and Rickettsiae families within the order Rickettsiales are main agents of tick-borne emerging diseases in humans and animals. Anaplasma marginale, a gram-negative intraerythrocytic bacterium, is one of the tick-transmitted etiological agents of the Anaplasmosis disease in cattle which causes dramatic weight lost, anemia, and often death during acute infection [16].
Anaplasma marginale invades and replicates in red blood cells during acute infection and can reach very high levels of erythrocyte infection. The acute infection in healthy animals usually resolves. However, this infection fails to be completely eliminated; which results in persistent infections that can be maintained over the entire life with fluctuating bacteremia levels [24]. The bacterium does not replicate in cells expressing MHC molecules. Besides, the available immunological data support that the A. marginale protective immunity mechanisms involve CD4+T cells response and INFγ production for the activation of macrophages which collaborate with B-cells in the induction of isotype switching to IgG2. The opsonization of bacteria or infected erythrocytes by activated macrophages enhanced phagocytosis along with cytokine and nitric oxide production; which leads to an incomplete intracellular bacteria clearence. In addition, high titers of fluctuating IgG1 and IgG2 antibodies directed to immunodominant major surface protein (MSP) were identified during the course of infection [11, 24].
The immunization with outer-membrane (OM)-enriched fractions of A. marginale has been shown to induce efficient protection against bacteremia and disease after experimental challenges [34, 40]. Mostly, the identification of immunogenic proteins has been focused on the six well-defined A. marginale major surface proteins (MSPs) [1, 6, 19, 38]. Up to date, vaccine trials using purified MSPs have conferred a variable range of protective responses. For instance, some MSPs act as immunodominant proteins, eliciting high IgG antibody responses. However, these studies have failed in demonstrating a clear association between the magnitude of the antibody response and a full control of infection or bacteremia levels [35]. Moreover, during persistent infections, immune response evasion mechanisms driven by antigenic variation of MSP-2 and MSP-3 impaired the protective capacity of these antigens [18, 19, 31]. Therefore, it has been postulated that conserved specific antigens play a critical role on contributing to the ability of complex immunogens to induce protection. For this reason, efforts have been concentrated on the study of these antigens [2, 3, 14, 15, 28, 29, 37].
Surface-expressed proteins are consistent candidates for vaccine development and suitable targets to either induce protective immunity in the mammalian host or to prevent colonization of host cells and the tick vector. Genome-wide studies have identified outer-membrane proteins (OMPs) broadly conserved among rickettsial pathogens [37]. Several studies on intracellular pathogens attempt to explore putative exposed proteins to contribute to the description of the surface proteome in A. marginale as well as other related intracellular pathogens, such as Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Neorickettsia sennetsu [21–23]; which will open a new spectrum of potential candidates derived from massive identification studies [32, 43]. Particularly, the A. marginale genome revealed 160 coding sequences containing transmembrane domains [9]. In this regard, the transmembrane β-barrel (TMBB) is the prevailing architecture of the membrane-spanning proteins found in the outer membranes of Gram-negative bacteria [46]. Genetic variability is relevant in the evaluation of candidates for the development of vaccines, as it can result in significant protein polymorphism and could impair cross-protection between isolates [39] and with Anaplasma centrale vaccine strain.
Considering OMPs are suitable targets to induce protective immunity, the present study focuses on the identification of novel putative membrane proteins of A. marginale to assess the conservation from local isolates compared with other known sequenced isolates and test their capability of inducing B- and T-lymphocyte responses. All three orthologs of the genes are present in related intracellular pathogens and the proteins they encode are interesting candidates to be considered as potential antigens for vaccine rational design.
Materials and Methods
Animals Used in this Study
We evaluated four one-year-old bovines: 3 naturally infected Angus raised in a farm located at Mercedes locality, Corrientes Province (Argentina) and a naïve Angus (non-infected) from the National Institute of Agricultural Technology (INTA) at Castelar, Buenos Aires Province. The naturally infected animals were assigned as follows: Nº 99 (acute phase of infection), Nº 282, and Nº 285 (chronic phase of infection). Additionally, we used an Angus animal Nº 640 during a experimentally infected assay with A. marginale str. Salta [42] for the immunoblot and real-time q-PCR analysis. In all cases, whole blood was collected in a heparinized microtube and DNA was subsequently extracted for PCR assays, as previously described [25]. Specific primers of msp5 from A. marginale str. Florida (GenBank accession M93392) were used to detect infection with A. marginale by heminested PCR (hnPCR) of msp5 gene, as previously described [45]. The experiments carried out in bovines reported in this manuscript were conducted following the Guide for the care and use of animals-INTA (Approved by resolution CICVyA No. 14/07) and internationally recognized guidelines of “Care and Use of Experimental Animals” as Guide for the Care and Use of Agricultural Animals in Research and Teaching, 3rd edition, 2010.
In Silico Analysis and Comparative Genomics
AM1108, AM127, and AM216 were amplified from genomic DNA of A. marginale local isolates (A. marginale str. Salta and A. marginale str. Mercedes) using specific primers based on A. marginale str. St Maries (Table S2). PCR amplicons were obtained with an automatic sequencer (ABI 3130, Applied Biosystems), assembled, and the consensus sequences were generated (Vector NTIv9). The obtained sequences for AM1108, AM127, and AM216 orthologs in both local strains were submitted to Genbank as follows: A. marginale str. Salta: KF053047, KF053049, and KF053051; A. marginale str. Mercedes: KF053048, KF053050, and KF053052. The gene localization in the genomic context and the predicted operons were obtained from the Database of prOkaryotic OpeRons [30] (Figure S3). For similarity searches and ortholog conservation analyses, BLASTP (e-value = 10−5; Query coverage >70 %) was applied. For sequence functional annotation, the gene ontology database Blast2GO tool [13] was used. The percentage of identity between the predicted amino acid sequences of the different strains were performed using ClustalW with MEGA 4 program [27, 44] compared to orthologs from A. marginale str. St Maries (Genbank CP000030), A. marginale str. Florida (Genbank CP001079), and A. centrale str. Israel (Genbank CP001759). Transmembrane β-strands and their topology with respect to the outer-membrane lipid bilayer were predicted using the posterior decoding method available at the PRED-TMBB [5]. PSORTb [20] was used for the protein subcellular localization analysis.
RNA Extraction and Transcription of Candidate Antigens in A. marginale
Total RNA from A. marginale str. Salta [36] was extracted from 2 ml of whole blood of the experimentally infected bovine Nº 640 using RNeasy RNA extraction kit (Qiagen) and the concentration and quality were subsequently determined with a nanodrop RNA/DNA calculator (NanoDrop Technologies). The cDNA synthesis for reverse transcription PCR (RT-PCR) was performed as previously described [36]. Specific primers were designed for this study (Table S1).
Amplification, Cloning, and Sequencing
For recombinant protein production, AM1108, AM127, and AM216 gene sequences were amplified from genomic DNA of the A. marginale str. St. Maries. The gene sequences of AM1108, AM127, and AM216 were split into two fragments (N-terminal and C-terminal) excluding the predicted signal peptide in order to improve recombinant protein production. Specific primers (Table S3) were designed for the amplification of these sequences. Six recombinant fragments were obtained: AM1108 N-term, AM1108 (complete open-reading frame), AM127 N-term, AM127 C-term, AM216 N-term, and AM216 C-term (Fig. S1). PCR products were cloned into pTOPO2.1 or pGEMT vectors (Invitrogen, USA) and then subcloned in pRSET or pBAD-Thio-TOPO expression vectors (Invitrogen, USA). Positive clones were sequenced with an automatic sequencer (ABI 3130, Applied Biosystems) to verify proper fusion frame and to discard nucleotide changes that could lead to frameshifting.
Expression of Recombinant Proteins in E. coli and Purification
Expression vectors containing each insert (AM1108 N-term, AM1108, AM127 N-term, AM127 C-term, AM216 N-term, or AM216 C-term) as 6xHis-tagged fusion were transformed in Escherichia coli BL21 and XLBlue strains (with pRSET or pBAD-Thio-TOPO, respectively). E. coli transformed cells were grown in LB broth at 37 °C and induced with 1 mM of IPTG or with a final concentration of 0.02 % of arabinose. Cells were harvested by centrifugation after 4-h induction. Then, pellets were resuspended in lysis buffer and disrupted by sonication under 8 M urea solution and protease inhibitors (Roche). Recombinant proteins were purified by anti-HIS immunoaffinity chromatography (ProBond Resin, Invitrogen) using a Ni2+-charged column under denaturing conditions and further elution using 125 mM to 1 M imidazole. Recombinant proteins were dialyzed overnight at 4 °C to diminish urea concentrations against a sterile phosphate-buffered saline solution (sterile PBS, pH 7.0). Purified recombinant proteins of the appropriate molecular weight were either tested in a sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Lymphocyte Proliferation Assays
For T-cell response evaluation, proliferation assays were performed using peripheral blood mononuclear cells (PBMC) purified from the three naturally infected animals (Nº 99, 282, and 285) and the non-infected animal (naïve). Blood samples extracted with heparin were collected and PBMC were purified using Histopaq (Sigma). Then, PBMC were cultured at 2.5 × 105 cells per well in 96-well plates at a final volume of 200 μl with RPMI medium supplemented with bovine fetal serum 10 % and incubated at 37 °C, 5 %CO2. PBMC-specific proliferation was assayed in quadruplicate wells with 100 μl culture media containing 1 μg/μl of recombinant proteins incubated for 4 or 6 days. Unspecific stimulation with Concanavalin A (ConA, 10 μg/ml) was assessed to confirm viability of PBMC. PBMC incubated with a non-related protein (BMFP) of Brucella melitensis biovar abortus 2308 were also analyzed as a negative control. After incubation, PBMC were radiolabeled for 18 h with 1 μCi of (methyl-3H) thymidine (Perkin Elmer), subsequently harvested onto glass filters and the amount of incorporated label was measured by liquid scintillation counting (Wallac, Winspectral). Proliferative responses are expressed as the stimulation index (SI) calculated as the mean count per minute (cpm) of cell cultures with the tested antigen/mean cpm of cells cultured in RPMI medium. Statistical analysis was determined by one-way ANOVA and with Bonferroni’s Multiple Comparison Test. Significance was retained when P < 0.05.
Immunoblotting
The recombinant proteins were subjected to 12 % SDS-PAGE and transferred to nitrocellulose membranes (Bio-Rad). The membranes were blocked with 5 % (m/v) non-fat dry powder milk at 4 °C overnight and incubated either with: serum from A. marginale-infected animal Nº 640, serum from animal Nº 640 previous to infection, serum from calves pre-immunized and immunized with A. marginale OM protein (provided by Dr. G. Palmer) [28] or the specific monoclonal antibody MAb ANAF16 against MSP-5 membrane protein. Blots were incubated for 2 h at room temperature, washed in PBS 1X, and subsequently incubated with the secondary antibodies: rabbit anti-bovine IgG Alkaline Phosphatase (Sigma) or goat anti-mouse Alkaline Phosphatase (Applied Biosystems) according to the case. The membranes were developed with BCIP/NBT solution (Promega).
Cytokine mRNA Analysis from PBMC
PBMC were extracted from the experimentally infected bovine (Nº 640), as described above. A total of 1 × 106 cells were incubated in duplicates with 1 μg/μl of recombinant proteins AM1108-ORF and AM216 C-term for 24 h. Total RNA was extracted using an RNeasy RNA extraction kit (Qiagen). Quality and quantity of total RNA were estimated by UV spectrophotometry (Nanodrop) and electrophoresis on 0.8 % agarose gel. DNA-free RNA (1 μg) was mixed with 1 μl (50 ng) of random primers (Invitrogen) at a final volume of 20 μl and reverse transcribed to total cDNA with SuperScript III reverse transcriptase (Invitrogen) following the manufacturer’s instructions. One microliter of the cDNA was used as a template for each real-time quantitative PCR (qPCR) reaction. Primers were designed using Primer Express Software 2.0 (Applied Biosystems) (Table S4). Tenfold serial dilutions of the cDNA were used to construct the standard curve and calculate the efficiency for each set of primers. Assays with a linear regression R value of >0.99 were considered acceptable. The qPCR reactions were performed in duplicate using SYBR green QuantiTec Mastermix (Qiagen) and standard cycling conditions (Applied Biosystem 7000). All qPCR data were analyzed by the 2−ddCt (exponential transformation, ddCt package) with efficiency correction using REST beta 9 software [41]. For each animal, PBMC incubated with RPMI medium without the recombinant proteins served as a control for calibration condition and pol II was used as the reference gene. Differences in the mRNA transcription levels between groups were evaluated by a non-parametric analysis performing a Pair Wise Fixed Reallocation Randomisation Test.
Results
Among the 949 annotated proteins in A. marginale str. St. Maries genome [9], 383 (40 %) remain as hypothetical proteins. The selection of hypothetical proteins for further characterization was based on the combination of experimental evidence using a pPhoA library of A. marginale for the selection of sequence coding for exported products (manuscript in preparation), in silico structure prediction, and orthology clustering. For AM1108, the multipass transmembrane β-prediction using PRED-TMBB showed significant predictions for a β-barrel OMPs (Fig. 1a). The conserved domain analysis identified a Pentapeptide Repeat domain (IPR001646; PF00805) strongly conserved within the Anaplasmatacea family and in all orders of the α-proteobacteria class (Table 1, Fig. 1d). For AM127, PRED-TMBB showed values that were statistically significant for β-barrel OMP prediction (Fig. 1b) and assigned a conserved domain of Acetamidase Formamidase conserved in almost all members of the class (Table 1; Fig. 1d). For AM216, this analysis also predicted a β-barrel protein (Fig. 1c). However, no conserved domains were identified for this protein, which is only conserved in Anaplasma spp. and Ehrlichia spp. (Table 1; Fig. 1d).
In order to determine the sequence similarity among the selected candidates between the American isolates (A. marginale str. St. Maries: AM1108, AM127, and AM216; A. marginale str. Florida: AMF_837, AMF_093, and AMF_157) and the local isolates from Argentina, we sequenced the target genes from two different isolates coming from separate geographical regions (for: A. marginale str. Salta: KF053047, KF053049, and KF053051, respectively; A. marginale str. Mercedes: KF053048, KF053050, and KF053052, respectively). Sequence analysis showed a high degree of conservation between the amino acid sequences from the local isolates, the American A. marginale strains, and the vaccine isolate A. centrale str. Israel (Table S7).
To confirm the transcription of the three candidate genes, total RNA was obtained from the local isolate A. marginale str. Salta and assessed by RT-PCR assays. Results were positive for the three genes in both organisms (Fig. 2). A. marginale str. St. Maries AM1108 N-term, AM1108 ORF, AM127 N-term, AM127 C-term, AM216 N-term, and AM216 C-term recombinant proteins were obtained (Fig. 3) for further characterization.
The infection with A. marginale was confirmed in the three naturally infected animals (Nº 99, 282, and 285) (Fig. S2). To analyze if these candidate proteins are able to elicit immunological responses, we performed proliferation assays with PBMC extracted from naturally infected animals and the non-infected naïve bovine (Fig. 4). AM1108-ORF induced a significant proliferative response of PBMC obtained from all infected cattle (Fig. 4b–d). AM216 C-term also showed a strong response when incubated with PBMC from the bovine Nº 99 (Fig. 4b). Although AM216 N-term and AM127 N-term also induced a specific response for this same animal, the proliferation response was weaker (Fig. 4b). The SI was much higher in the acutely infected animal (Nº 99) compared with the chronic-infected bovines (Nº 282 and Nº 285). The same trend was observed for the proliferation assays incubated for 4 or 6 days. PBMC from all animals failed to respond significantly to the unrelated Brucella abortus recombinant protein BMFP (Fig. 4a). Furthermore, no response was observed with any of the recombinant antigens tested for the naïve non-infected animal (Fig. 4a). PBMC from all animals showed a strong unspecific response to ConA indicating viability during the proliferation assay (Table S5).
We also evaluated humoral response against recombinant antigens using sera from bovines immunized with an OM-enriched fraction and from experimentally infected cattle (Nº 640). Both sera recognized AM1108; which confirms the presence of specific antibodies against this protein (Fig. 5a). No detectable levels of specific antibodies were observed for the other tested recombinant proteins (data not shown). The lack of a detectable antigen–antibody interaction could be attributed to the absence of conformational epitopes in the recombinant versions of these proteins or to low undetectable antibody titers. Another possible explanation could be that these antibodies were present in a different time point in which this antigen was evaluated. Positive reactivity to MSP-5 was also analyzed as a positive control of the sera used for the assays (Fig. 5b).
For the evaluation of the cytokine response to the candidate recombinant antigens of A. marginale, the levels of the mRNA transcripts for IL-2, IL-10, IL-12p35, TNF-α, and IFN-γ were measured by q-PCR, These measurements were assessed in three independent experiments. The q-PCR assays were performed on PBMC extracted from blood samples collected from the experimentally infected animal Nº 640 during the acute stage of infection, after stimulation with the proteins under study. TNF-α and IFN-γ were significantly upregulated by AM1108 and AM216 C-term, respectively (P < 0.05) (Table S6).
Discussion
Even though considerable research efforts have been undertaken, Anaplasmosis vaccine development remains a challenging field. In Argentina, vaccination with the less virulent strain A. marginale subspecies centrale is the currently available protection strategy [4]. This live vaccine has been also largely used in Australia, South Africa, Uruguay, and Israel. However, breaks in vaccine protection [8] and the risk of disease induced by live vaccine strains themselves have prompted the search for better control alternatives. In this regard, immunization with outer membranes can induce sterile protective immunity against challenge with A. marginale [12]. Nevertheless, only partial immunity against heterologous challenge has been achieved. In addition, it has been shown that antibodies induced by A. marginale subspecies centrale live vaccine bound to OMPs that overlapped with OMPs that were immunogenic in animals vaccinated with inactivated vaccines and subsequently protected against bacteremia and disease. These identified OMPs are absent in the most immunodominant antigens (MSP-2 and MSP-3), supporting the hypothesis that protective immunity against A. marginale is associated to subdominant antigens [29]. In addition, these antigens appear to be less variable; which makes them good targets to be included in a broadly protective vaccine and their identification represents a major goal in the development of bacterial vaccines.
Ortholog proteins of AM1108 were identified in almost all organisms from the order Rickettsiales and several studies in related pathogens described them as surface-exposed proteins in A. phagocytophilum (APH_1170) [21], E. chaffeensis (ECH_1083) [22], and N. sennetsu (NSE_0725) [23]. Furthermore, AM1108 is highly conserved (>99 % identity) at the amino acid level among the distinct strains (Table S7) and is also conserved in the A. centrale str. Israel genome with 73 % of identity. In this study we showed that the recombinant AM1108 protein elicits lymphocyte proliferation and a rise in TNF-α mRNA levels. Furthermore this protein was recognized by sera either from animals immunized with OM-enriched fractions or from infected cattle. These results are consistent with the expression of this protein during infection, the expected cellular location and its potential to be considered as a vaccine candidate. Pentapeptide repeat domains were first identified in many cyanobacterial proteins and later on they were also found in bacterial and plant proteins [26]. The function of these repeats is still unknown and their predicted structure is a beta-helix [7]. Moreover, AM1108 and AM127 were described as part of the cluster three of orthologs conserved across all representative obligate and facultative intracellular pathogens and endosymbionts [17].
Recently, proteomic and immunologic studies using sera from cattle immunized with OM-enriched fractions have identified 24 surface-expressed OMPs including the AM127 hypothetical protein [29, 37]. In this study, AM127 was predicted to have six membrane β-strands suggesting a β-barrel outer membrane; which supports previous experimental evidence [29]. In addition, AM127 orthologs are present in almost all members of the α-proteobacteria class, absolutely conserved within A. marginale strains and also in the A. centrale (with 86 % identity). We further confirmed the transcription of the AM127 gene, at least in the intraerythrocytic stage. Interestingly, AM127 is the only one of the three analyzed genes that participate in an operon (code 84921) with rnhA gene encoding for RnhA ribonuclease H protein (COG0328) (Figure S3). AM127 was annotated as a hypothetical protein and lacked of associated information in the genome project [9]. However, Blast2GO annotation matched with an acetamidase formamidase domain which was also identified in the ortholog protein of A. phagocytophilum (APH_0110). The PBMC assays showed a significant stimulation using AM127 N-term. However, no IgGs-specific antigen recognition was detected in Western blot assays.
AM216 protein belongs to a cluster retained only in Anaplasma spp. and Ehrlichia spp. without orthologs in other families of the class. However, none of them was identified by other studies and no information associated with conserved domains has been reported. Although bioinformatic analysis of the subcellular localization predicted AM216 as an OMP, no evidence of specific recognition of sera from infected or immunized animals have been detected in the study. The results of PBMC stimulation with AM216 elicited a significant proliferative response with concomitant increased levels of IFN-γ mRNA, one of the cytokines described as relevant in the course of A. marginale infection (Table S6) [11].
As A. marginale does not replicate within cells that express MHC molecules, current hypotheses of protective immunity are focused on CD4+ T cell activation and B-cell isotype switching to high-affinity IgG isotypes. These antibodies promote opsonization of bacteria and, therefore, INF-γ secretion. Both processes play a key role in the activation of macrophages to produce TNF-α and nitric oxide (NO) and also activate IgG2 production by B-cells [10, 11, 33]. AM1108 and AM216 C-term induced TNF-α and IFN-γ transcription, respectively. In addition, both recombinant proteins elicited significant lymphoproliferation. Besides, AM1108 was recognized by specific antibodies from bovines with acute anaplasmosis. Therefore, AM1108 and AM216 C-term could be involved in immune response pathways of the acute phase and could be posed to be important during the bacteremia control. Further immunological characterization must be carried out in order to demonstrate the role of both candidates in the protection of persistently infected cattle.
Taken together, bioinformatic and experimental evidence in this work allowed the identification of new putative OM proteins of A. marginale with the ability to elicit B- and T-cell responses. Immunological specific response represents an indirect evidence of protein expression along the time course of the infection. Further studies are required to confirm the surface location and the potential of the selected candidates as effective antigens for being included in rational vaccine strategies.
References
Abbott JR et al (2004) Anaplasma marginale major surface protein 2 CD4+-T-cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR. Infect Immun 72(12):7360–7366
Agnes JT et al (2011) Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine. Infect Immun 79(3):1311–1318
Albarrak SM et al (2012) Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity. PLoS One 7(9):e46372
Anziani OS et al (1987) Vaccination with Anaplasma centrale: response after an experimental challenge with Anaplasma marginale. Trop Anim Health Prod 19(2):83–87
Bagos PG et al (2004) PRED-TMBB: a web server for predicting the topology of beta-barrel outer membrane proteins. Nucleic Acids Res 32:W400–W404 Web Server issue
Barbet AF et al (2001) Antigenic variation of Anaplasma marginale: major surface protein 2 diversity during cyclic transmission between ticks and cattle. Infect Immun 69(5):3057–3066
Bateman A, Murzin AG, Teichmann SA (1998) Structure and distribution of pentapeptide repeats in bacteria. Protein Sci 7(6):1477–1480
Bock RE, de Vos AJ (2001) Immunity following use of Australian tick fever vaccine: a review of the evidence. Aust Vet J 79:832–839
Brayton KA et al (2005) Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proc Natl Acad Sci USA 102(3):844–849
Brown WC (2012) Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence. Comp Immunol Microbiol Infect Dis 35(3):241–252
Brown WC (2008) Unraveling the immune regulatory mechanisms imposed by Anaplasma. Vet J 175(1):10–11
Brown WC et al (1998) CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect Immun 66(11):5406–5413
Conesa A et al (2005) Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics 21(18):3674–3676
Dark MJ, Al-Khedery B, Barbet AF (2011) Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale. Vaccine 29(31):4923–4932
Dark MJ, Lundgren AM, Barbet AF (2012) Determining the repertoire of immunodominant proteins via whole-genome amplification of intracellular pathogens. PLoS One 7(4):e36456
Dumler JS et al (2001) Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 51(Pt 6):2145–2165
Dunning Hotopp JC et al (2006) Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet 2(2):e21
French DM, Brown WC, Palmer GH (1999) Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia. Infect Immun 67(11):5834–5840
French DM et al (1998) Expression of Anaplasma marginale major surface protein 2 variants during persistent cyclic rickettsemia. Infect Immun 66(3):1200–1207
Gardy JL et al (2003) PSORT-B: improving protein subcellular localization prediction for Gram-negative bacteria. Nucleic Acids Res 31(13):3613–3617
Ge Y, Rikihisa Y (2007) Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics. J Bacteriol 189(21):7819–7828
Ge Y, Rikihisa Y (2007) Surface-exposed proteins of Ehrlichia chaffeensis. Infect Immun 75(8):3833–3841
Gibson K, Kumagai Y, Rikihisa Y (2010) Proteomic analysis of Neorickettsia sennetsu surface-exposed proteins and porin activity of the major surface protein P51. J Bacteriol 192(22):5898–5905
Han S et al (2010) Anaplasma marginale infection with persistent high-load bacteremia induces a dysfunctional memory CD4+T lymphocyte response but sustained high IgG titers. Clin Vaccine Immunol 17(12):1881–1890
Higuchi R (1989) Rapid, efficient DNA extraction for PCR from cells or blood. Amplifications 2:1–3
Kieselbach T et al (1998) Characterisation of an Arabidopsis cDNA encoding a thylakoid lumen protein related to a novel ‘pentapeptide repeat’ family of proteins. FEBS Lett 428(3):241–244
Larkin MA et al (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23(21):2947–2948
Lopez JE et al (2007) Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine. Infect Immun 75(5):2333–2342
Lopez JE et al (2005) Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun 73(12):8109–8118
Mao F et al (2009) DOOR: a database for prokaryotic operons. Nucleic Acids Res 37:D459–D463 Database issue
Meeus PF, Barbet AF (2001) Ingenious gene generation. Trends Microbiol 9(8):353–355 discussion 355-6
Morse K et al (2012) Association and evidence for linked recognition of Type IV secretion system proteins VirB9-1, VirB9-2, and VirB10 in Anaplasma marginale. Infect Immun 80(1):215–227
Nazifi S et al (2012) Acute phase response in cattle infected with Anaplasma marginale. Vet Microbiol 155(2–4):267–271
Noh SM et al (2008) Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization. Infect Immun 76(5):2219–2226
Noh SM et al (2010) The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity. Vaccine 28(21):3741–3747
Nunez PA, Soria M, Farber MD (2012) The twin-arginine translocation pathway in alpha-proteobacteria is functionally preserved irrespective of genomic and regulatory divergence. PLoS One 7(3):e33605
Palmer G et al (2012) Genome-wide screening and identification of antigens for rickettsial vaccine development. FEMS Immunol Med Microbiol 64:115–119
Palmer GH et al (1998) Persistence of Anaplasma ovis infection and conservation of the msp-2 and msp-3 multigene families within the genus Anaplasma. Infect Immun 66(12):6035–6039
Palmer GH, Brown WC, Rurangirwa FR (2000) Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginale. Microbes Infect 2(2):167–176
Palmer GH et al (1994) Heterologous strain challenge of cattle immunized with Anaplasma marginale outer membranes. Vet Immunol Immunopathol 42(3–4):265–273
Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30(9):e36
Ruybal P et al (2009) Genetic diversity of Anaplasma marginale in Argentina. Vet Parasitol 162(1–2):176–180
Sutten EL et al (2010) Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine. Infect Immun 78(3):1314–1325
Tamura K et al (2007) MEGA4: molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24(8):1596–1599
Torioni de Echaide S et al (1998) Detection of cattle naturally infected with Anaplasma marginale in a region of endemicity by nested PCR and a competitive enzyme-linked immunosorbent assay using recombinant major surface protein 5. J Clin Microbiol 36(3):777–782
Wimley WC (2003) The versatile beta-barrel membrane protein. Curr Opin Struct Biol 13(4):404–411
Acknowledgments
This research was supported by Epigenevac Project (FP6-2002-INCO-DEV-1, EU) and Agencia Nacional de Promoción Científica y Técnica de Argentina (AGENCIA; PICT-2008-0832 to MF). PN holds a postdoctoral fellowship from the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET); PR, SW, and MF are members of CONICET Researcher’s Career.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Nuñez, P.A., Moretta, R., Ruybal, P. et al. Immunogenicity of Hypothetical Highly Conserved Proteins as Novel Antigens in Anaplasma marginale . Curr Microbiol 68, 269–277 (2014). https://doi.org/10.1007/s00284-013-0475-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-013-0475-6